Literature DB >> 31514702

Response by Fitzgerald and Brinjikji to Letter Regarding Article, "Platelet-Rich Emboli in Cerebral Large Vessel Occlusion Are Associated With a Large Artery Atherosclerosis Source".

Seán Fitzgerald1, Waleed Brinjikji1.   

Abstract

Entities:  

Year:  2019        PMID： 31514702      PMCID： PMC6912597          DOI： 10.1161/STROKEAHA.119.026856

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  4 in total

1.  Studies on the character and staining of fibrin.

Authors:  A C LENDRUM; D S FRASER; W SLIDDERS; R HENDERSON
Journal:  J Clin Pathol       Date:  1962-09       Impact factor: 3.411

2.  Platelet-Rich Emboli in Cerebral Large Vessel Occlusion Are Associated With a Large Artery Atherosclerosis Source.

Authors:  Seán Fitzgerald; Daying Dai; Shunli Wang; Andrew Douglas; Ramanathan Kadirvel; Kennith F Layton; Ike C Thacker; Matthew J Gounis; Ju-Yu Chueh; Ajit S Puri; Mohammed Almekhlafi; Andrew M Demchuk; Ricardo A Hanel; Eric Sauvageau; Amin Aghaebrahim; Albert J Yoo; Peter Kvamme; Vitor M Pereira; Yasha Kayan; Josser E Delgado Almandoz; Raul G Nogueira; Alejandro A Rabinstein; David F Kallmes; Karen M Doyle; Waleed Brinjikji
Journal:  Stroke       Date:  2019-05-29       Impact factor: 7.914

Review 3.  Mechanisms of thrombus formation.

Authors:  Bruce Furie; Barbara C Furie
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

4.  Platelet-rich clots as identified by Martius Scarlet Blue staining are isodense on NCCT.

Authors:  Sean T Fitzgerald; Shunli Wang; Daying Dai; Andrew Douglas; Ramanathan Kadirvel; Matthew J Gounis; Juyu Chueh; Ajit S Puri; Kennith F Layton; Ike C Thacker; Ricardo A Hanel; Eric Sauvageau; Amin Aghaebrahim; Mohammed A Almekhlafi; Andrew M Demchuk; Raul G Nogueira; Vitor M Pereira; Peter Kvamme; Yasha Kayan; Josser E Delgado Almandoz; Albert J Yoo; David F Kallmes; Karen M Doyle; Waleed Brinjikji
Journal:  J Neurointerv Surg       Date:  2019-04-05       Impact factor: 5.836
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.